About 400 reports

  • Diagnosis of lymphoma
  • Tests for lymphoma
  • Lymphoma
  • Forecast
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Lymphoma Treatment Drugs Imports and Exports
  • IV. LYMPHOMA TREATMENT DRUGS PRODUCTION AND
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • III. LYMPHOMA
  • Lymphoma Treatment Drugs Industry Structure
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Ltd Jiangsu Hengrui Medicine Co.
  • Ltd Shenzhen Main Luck Pharmaceuticals Inc.
  • Lymphoma Treatment Drugs Exports
  • Other Lymphoma Treatment Drugs
  • Lymphoma
  • China
  • Demand
  • Trade
  • Pfizer Inc.
  • Marketed Drugs: Follicular Lymphoma
  • Pipeline: Follicular Lymphoma
  • Lymphoma
  • Europe
  • Japan
  • Biogen Idec Inc.
  • Roche Group
  • Epidemiology: Mantle Cell Lymphoma
  • Forecast: Mantle Cell Lymphoma
  • Lymphoma
  • Europe
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group
  • Ann Arbor staging used in lymphoma
  • Marketed Drugs: Diffuse Large B-Cell Lymphoma
  • Lymphoma
  • Europe
  • Japan
  • Celgene Corporation
  • Roche Group

Indolent Lymphoma - Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

B-Cell Lymphomas - Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

Small lymphocytic lymphoma -Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

Indolent Lymphoma : ##MM Market Analysis ##. ##. ##MM Market Size of Indolent Lymphoma ##. ##. ##MM Percentage Share of drugs marketed for Indolent Lymphoma ##. ##. ##MM Market Sales of Indolent Lymphoma by Products ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

B-Cell Lymphomas : ##MM Market Analysis ##. ##. ##MM Market Size of B-Cell Lymphomas ##. ##. ##MM Percentage Share of drugs marketed for B-Cell Lymphomas ##. ##. ##MM Market Sales of B-Cell Lymphomas by Products ##.

  • Cancer
  • Lymphoma

Small lymphocytic lymphoma : ##MM Market Analysis ##. ##. ##MM Market Size of Small lymphocytic lymphoma ##. ##. ##MM Percentage Share of drugs marketed for Small lymphocytic lymphoma ##. ##. ##MM Market Sales of Small lymphocytic lymphoma by Products ##.

  • Cancer
  • Lymphoma
  • 9.27 Lymphoma, Hodgkin's - Market & Forecast
  • 10.27 Lymphoma, Hodgkin's - Patient Numbers & Forecast
  • Lymphoma
  • North America
  • United States
  • Forecast
  • Market Size
  • NON-HODGKIN LYMPHOMA

The various malignant tumors are further classified into sarcomas, carcinomas, and lymphomas.

  • Lymphoma
  • Transplantation
  • World
  • Forecast
  • Merck & Co., Inc.
  • 3.5.1 Follicular Lymphoma
  • 3.5.2 Marginal Zone Lymphoma
  • Lymphoma
  • Germany
  • Japan
  • Spain
  • Forecast
  • 5.2.6 LYMPHOMA
  • INCYTE CORPORATION
  • Lymphoma
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • LYMPHOMA MARKET BY DRUG TYPE ($ MILLIONS)
  • Chapter 9: Pipeline Disruptors: Lymphoma
  • Lymphoma
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • LYMPHOMA (CHL)
  • COMBINATION REGIMENS FOR DIFFERENT TYPES OF LYMPHOMAS
  • Lymphoma
  • United States
  • Demand
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • 6.27 Lymphoma, Hodgkin's - Market & Forecast
  • 7.28 Lymphoma, Non-hodgkin's - Patient Numbers & Forecast
  • Lymphoma
  • North America
  • United States
  • Forecast
  • Mitsubishi Corporation
  • B-CELL LYMPHOMAS
  • Incidence of Burkitt's Lymphoma, (000s)
  • Lymphoma
  • Asia
  • Europe
  • North America
  • Market Size
  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size

(% market share) CHAPTER ##: PIPELINE DISRUPTORS: LYMPHOMA MARKET OPPORTUNITY Non-Hodgkin' s Lymphoma Table ##-##: Classification of Non-Hodgkin' s Lymphomas Hodgkin' s Lymphoma Figure ##-##: Global Incidence and Mortality of Lymphoma by Country, 2012* THE HEAVY HITT

  • Lymphoma
  • Oncology
  • Pathology
  • World
  • Market Size
  • LYMPHOMA
  • LYMPHOMA
  • Lymphoma
  • Demand
  • Market Size
  • AbbVie Inc.
  • Seattle Genetics, Inc.
  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size

Global Non-Hodgkin' s Lymphoma Epidemiology and Patient Flow Analysis - 2016 ##.

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • 4.2.1 Follicular Lymphoma
  • 5.5.1 Follicular Lymphoma
  • Lymphoma
  • AbbVie Inc.
  • GlobalData's company
  • Novartis AG
  • Roche Group

The 2019-2024 World Outlook for Non-Hodgkin Lymphoma (NHL) Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lymphoma
  • Demand

Europe Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lymphoma
  • Europe
  • France
  • Germany
  • Forecast